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As a result of brain injury, astrocytes become acti-
vated and start to proliferate in the vicinity of the
injury site. Recently, we had demonstrated that these
reactive astrocytes, or glia, can form self-renewing
and multipotent neurospheres in vitro. In the present
study, we demonstrate that it is only invasive injury,
such as stab wounding or cerebral ischemia, and
not noninvasive injury conditions, such as chronic
amyloidosis or induced neuronal death, that can elicit
this increase in plasticity. Furthermore, we find that
Sonic hedgehog (SHH) is the signal that acts directly
on the astrocytes and is necessary and sufficient
to elicit the stem cell response both in vitro and
in vivo. These findings provide a molecular basis for
how cells with neural stem cell lineage emerge at
sites of brain injury and imply that the high levels of
SHH known to enter the brain from extraneural sour-
ces after invasive injury can trigger this response.
INTRODUCTION
Reactive gliosis is the prototypical response of the central
nervous system (CNS) to diverse types of injury mediated by426 Cell Stem Cell 12, 426–439, April 4, 2013 ª2013 Elsevier Inc.various cell types and involves the activation of microglia and
all classes of macroglia: oligodendrocytes, NG2+ glia, and astro-
glia (Go¨ritz et al., 2011; Robel et al., 2011a; Sofroniew, 2009).
Recently, cells reacting to injury have been observed to reacti-
vate stem cell potential (Robel et al., 2011a), but the signals elic-
iting this response remain undefined. After traumatic brain injury,
a significant fraction of the cells isolated from injured CNS tissue
has been shown to generate multipotent, self-renewing cells
in vitro (Barnabe´-Heider et al., 2010; Buffo et al., 2008; Lang
et al., 2004; Sirko et al., 2009). Genetic fate mapping identified
a subtype of reactive astrocytes in the forebrain gray matter
(GM) as the source of the cells that exhibit such neural stem
cell (NSC) properties in vitro (Buffo et al., 2008), while in the spinal
cord ependymal cells display these hallmarks (Barnabe´-Heider
et al., 2010).
Cells that can take on an NSC character after injury could
provide an important new resource for endogenous repair and
could be particularly valuable in the case of neurodegenerative
diseases associated with widespread neuronal damage, such
as Alzheimer’s disease (AD) (Duyckaerts et al., 2009; Rodrı´guez
et al., 2009). This prompts the question of the extent to which
chronic neurodegeneration may actually elicit an NSC response.
We addressed this question by comparing responses to acute
ischemic lesion, traumatic injury, progressive (chronic) amyloid
plaque deposition, and a noninvasive model of widespread
neuronal death. To study the effects of progressive plaque depo-
sition, we took advantage of APPPS1 mice. This mouse strain
Figure 1. Reactive Gliosis and Proliferation
in the Cerebral Cortex of APPPS1 Mice
(A) Representative micrographs of Ab plaques
detected by the monoclonal antibody (mAb) 6E10
in the cerebral cortex of APPPS1 mice at 3, 6, and
11 months of age. High-power views of sections
stained with 6E10 and anti-GFAP are shown in (B).
(C) Examples of hypertrophic astrocytes in
APPPS1 mice at the ages indicated. (D) Distribu-
tion of GFAP- and nestin-expressing cells in the
cerebral cortex of 6-month-old APPPS1 mice, and
high-power views of separate (D0 and D00) and
merged (D00 0) signals. (E–H) Proliferation activity
(BrdU-labeled cells) and immunohistochemical
characterization of cell types in the cerebral cortex
of APPPS1 mice of the indicated age. The data are
quantified in the histograms shown in (F) and (H)
as mean number (±SEM) per area in a section
analyzed from 3–11 animals. Significant differ-
ences relative to controls are indicated by aster-
isks based on the p value. For additional analysis
of the cerebral cortex of APPPS1 mice, see Fig-
ure S1. Scale bars: (A) and (B), 100 mm; (C) and (E),
50 mm; (D) and (G); 20 mm.
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SHH Mediates Stem Cell Response of Reactive Gliacarries the Swedish double mutation, which results in overex-
pression of mutant forms of both the amyloid precursor protein
(APP) and presenilin 1 (PS1) in neurons (Radde et al., 2006;
Rupp et al., 2011). The consequences of endogenously induced
neuronal death on reactive glia were examined after targeted
activation of p25 expression in neurons of the cerebral cortex.
This activator of cyclin-dependent kinase 5 (CDK5) elicits exten-
sive loss of neurons, tau pathology, and intraneuronal Ab accu-Cell Stem Cell 12, 426–mulation, thus mimicking further hall-
marks of AD (Cruz et al., 2003, 2006).
Analysis of these acute and chronic
models revealed striking differences in
the proliferative response of reactive glia
and the appearance of cells with NSC
properties, which enabled us to identify
Sonic hedgehog (SHH) as a key regulator
of the stem cell response in reactive glia.
RESULTS
Reactive Astrocytes Show Low
Proliferative Activity in APPPS1
Mice
To examine the glial reaction over time
in the presence of continuing amyloid
plaque deposition, we first used immuno-
staining for Ab to visualize amyloid pla-
ques at 3 months of age in the brains of
APPPS1 mice (Radde et al., 2006) and
their subsequent spread throughout the
cerebral cortex within the next months
(Figure 1A). Hypertrophic astrocytes that
were immunoreactive for glial fibrillary
acidic protein (GFAP) were mostly
located in the vicinity of plaques in3-month-old APPPS1 (APPPS1-3mo) mice and were detected
in all neuronal layers at later times (Figures 1B and 1C). Many
reactive astrocytes located in the GM of the cerebral cortex
were also found to express proteins characteristic of immature
glia or NSCs, such as nestin (Figure 1D), the membrane-associ-
ated proteoglycan DSD1 (the 473HD epitope), and tenascin-C
(TNC, Figures S1A and S1B available online), all of which are
typically upregulated in reactive astrocytes (Robel et al., 2011a).439, April 4, 2013 ª2013 Elsevier Inc. 427
Figure 2. Reactive Gliosis and Proliferation in the Cerebral Cortex of the CK/p25 Mouse Model
(A) The diagram schematically depicts the constructs and regulatory strategy used to induce neuronal expression of p25. CK mice expressing the transactivator
domain (TTA) under the CAMKII promoter were crossed with p25 mice expressing p25-GFP under the control of the Tet operon (Tet-O) promoter. Upon with-
drawal of doxycycline (Dox), p25 is expressed in CAMKII-positive neurons in double-transgenic mice.
(B–E) Phenotypes of CK/p25 mice at various times after doxycycline withdrawal (B, C, and E), with (B) providing an overview and (C) and (E) showing astrocytes
(GFAP+) and microglia (Iba1+) at higher magnifications (insets in C). Double-labeled cells are indicated by white arrowheads and single BrdU-labeled cells by
empty arrowheads. The histogram in (D) provides a quantitative summary of the data, presented as mean (±SEM) per area in a section for three to seven
animals. Significant differences relative to controls are indicated based on the p value. For additional analysis of the cerebral cortex of CK/p25mice see Figure S2.
Scale bars: (B), 200 mm; (C), 50 mm; insets: (C), 10 mm; (E), 20 mm.
Cell Stem Cell
SHH Mediates Stem Cell Response of Reactive GliaTo determine whether these reactive astrocytes also prolif-
erate, we provided the DNA base analog BrdU in the drinking
water for 2 weeks. The incidence of BrdU-labeled cells was
significantly increased in APPPS1-3mo mice relative to controls,
and their numbers further increased thereafter (Figure 1F).
Surprisingly, however, only 2.7% of all BrdU+ cells also ex-
pressed the astrocyte markers GFAP and/or S100b (Figures
1G and 1H), and this population accounted for as little as 1.1%
of all astrocytes in the GM of APPPS1-6mo mice, while up to
50% of astrocytes incorporate BrdU after stab wound (Buffo
et al., 2008). Conversely, Iba1+ microglia showed a strikingly
robust proliferative response, constituting the majority of prolif-
erating cells (Figures 1G and 1H), while the remaining 40% of
the proliferative glial cell pool in the GM of APPPS1-6mo mice
was composed of NG2+ glia (Figures 1G and 1H).428 Cell Stem Cell 12, 426–439, April 4, 2013 ª2013 Elsevier Inc.Lack of Proliferation of Astrocytes or NG2 Cells after
Widespread Neuronal Death Elicited by p25
Overexpression in the Cerebral Cortex
Given the virtual absence of cell death in APPPS1 mice (Rupp
et al., 2011), we examined the glial reaction after neuronal
overexpression of p25 induced by doxycycline withdrawal in
CK/p25 mice at 6 weeks of age (Figure 2A, Cruz et al., 2003,
2006). Neuronal cell death became manifest within 2 weeks
(CK/p25-2w) and resulted in profound shrinkage of the GM
within 5 weeks (CK/p25-5w) (Figure 2B, Figures S2A and
S2B). Reactive gliosis, as monitored by immunostaining for
GFAP and Iba1, was clearly increased 14 days after p25 induc-
tion, while it is absent or less pronounced in controls (Figure 2C).
Strikingly, the only glial cells to show increased proliferation
were microglia (>1003), while neither astrocytes nor NG2 glia
Cell Stem Cell
SHH Mediates Stem Cell Response of Reactive Gliaincreased their proliferation rate despite the massive neuronal
cell death (Figures 2D and 2E).
As described previously (Simon et al., 2011), virtually all cells
found to proliferate in the GM of controls for APPPS1 (6 months)
and CK/p25 (3 months) (Figures 1H and 2D) are NG2 glia, and
their rate of proliferation decreases with age in controls (Fig-
ure 1F; see also Behrendt et al., 2013).
Invasive Injury Models Evoke Neurosphere Formation in
Cells of Cerebral Cortex GM
While reactive astrocytes failed to proliferate in the above nonin-
vasive models, they upregulated proteins also present in
NSCs, such as nestin, the proteoglycan DSD1, or TNC (Figures
S1 and S2C). This prompted us to probe their potential for neuro-
sphere formation by isolating a defined volume of GM from the
somatosensory cortex of noninjured controls, APPPS1 mice,
and CK/p25 mice and plating the cells at clonal density (one to
five cells/ml) for 14 days in vitro (div). Intact, uninjured GM gave
rise to virtually no neurospheres, and only few neurospheres
emerged from the GM of the APPPS1-6mo mice, although reac-
tive gliosis was prominent at this age (Figures 3A and 3B). The
few neurospheres that did form, however, exhibited the typical
hallmarks of true stem cells: they could be passaged and were
capable of self-renewal, as indicated by the formation of
secondary neurospheres (Figure 3B). One-third of the neuro-
spheres were also multipotent and generated neurons, astro-
cytes, and oligodendrocytes when exposed to differentiation
conditions for 7 div (Figure 3C). This degree of multipotency is
quite comparable to that of spheres generated from stab-
wound-injured or laser-lesioned cerebral cortex (Buffo et al.,
2008; Sirko et al., 2009). Because reactive astrocytes labeled
byGLASTCreERT2-mediated recombination generated most neu-
rospheres after stab wound injury (Buffo et al., 2008), we crossed
GLASTCreERT2, a knockin mouse line that faithfully expresses
CreERT2 in GLAST+ cells, and a GFP reporter line (Nakamura
et al., 2006) with APPPS1 mice (Figure S3A) to trace the origin
of the few neurospheres formed upon amyloidosis. At the
dosage of tamoxifen used for fate mapping, this population
consists mostly of astrocytes in the GM of the cerebral cortex
(Figures S3A and S3B; Mori et al., 2006; Buffo et al., 2008; Robel
et al., 2011b). All neurospheres derived from the cerebral cortex
of 6-month-old APPPS1;GLASTCreERT2;CAG-eGFP mice that
received tamoxifen 30 days before they were sacrificed were
GFP+ (Figure S3C). Thus, the few self-renewing and multipotent
cells with neurosphere-forming capabilities that appear during
chronic amyloidosis in the GM of the cerebral cortex must be
derived from GLAST+ astrocytes. Contrary to our initial hypoth-
esis that massive neuronal cell death should elicit a stronger
NSC response, virtually no primary spheres, and no secondary
neurospheres at all, formed from cells isolated from 3-month-
old CK/p25 mice 5 weeks after doxycycline withdrawal (Fig-
ure 3B). Thus, both of these noninvasive models of pathology
largely fail to elicit neurosphere formation and prompt a rather
low proliferative response of the reactive astrocytes, the popula-
tion responsible for generating most neurospheres.
Indeed, in injury models with higher rates of astrocyte prolifer-
ation, such as acute invasive injury, we observed a striking differ-
ence in the stem cell response.When cells were isolated from the
tissue adjacent to a stab wound or the region that had been sub-jected to focal cerebral ischemia upon occlusion of the middle
cerebral artery (MCAo) with a filament for 1 hr (Plesnila et al.,
2004) at 3 days postinjury (3 dpi), we observed a 5-fold increase
in the frequency of neurosphere formation compared to APPPS1
mice (Figures 3A and 3B; 45% of neurospheres from MCAo ex-
hibited multipotency, data not shown). Thus, within 3 days after
acute invasive injury, the neurosphere-forming response has
reached a significant level, equivalent to one-fifth of the maximal
incidence of stem cells obtainable from cells of the subependy-
mal zone (SEZ). In models of chronic noninvasive injury, in
contrast, such a response is virtually or totally absent.
These models may either fail to elicit a latent stem cell poten-
tial or, alternatively, reactive glia/astrocytes may be prevented
from manifesting such potential by inhibitory signals, such as
aberrant Notch signaling due to the mutant form of presenilin
present in the neurons of APPPS1 mice (De Strooper et al.,
1999; Radde et al., 2006; Veeraraghavalu et al., 2010) or the
toxicity of Ab amyloid. To address the first possibility, APP23
mice overexpressing only mutant APP, but not aberrant PS1
(Sturchler-Pierrat et al., 1997), were investigated at a comparable
stage of amyloidosis, at 12 months of age (Boncristiano et al.,
2005; Radde et al., 2006; Sturchler-Pierrat et al., 1997). Cells iso-
lated from these mice gave rise to comparably small number of
neurospheres (Figure S3D), indicating that this trait cannot be
attributed to the aberrant PS1 expression in APPPS1 mice.
Next, APPPS1-9mo mice were subjected to stab wounding,
and here we detected a significant increase in the number of
primary and secondary neurospheres generated from cells ob-
tained at 3 dpi compared to age-matched APPPS1 mice (Fig-
ure 3D). Moreover, the number of neurospheres formed was
not significantly different from that observed when cells from
age-matched control mice lacking amyloidosis were tested (Fig-
ure 3D). These findings indicate that cells with the potential to
form neurospheres are still present in APPPS1 mice, but are
largely impervious to activation by the signals elicited by amyloid
plaque deposition.
Interestingly, in the course of the above experiments, we
noted that age had a strong influence on the rate of neuro-
sphere formation after stab wound injury. Cells isolated at either
3 or 5 dpi from the cortex of 6- or 9-month-old mice subjected
to stab wounding gave rise to 2- to 3-fold fewer neurospheres
than cells obtained from 3-month-old mice (Figure 3E). How-
ever, irrespective of age, stab wound injury always elicits the
appearance of a significantly higher number of neurospheres
than does amyloidosis (Figure 3E), and no neurospheres have
yet been obtained from the cortex of APPPS1-3mo mice, sug-
gesting that the degree of amyloidosis and reactive gliosis at
this point is too low to elicit any neurosphere formation at all
(Figure 3E).
Levels of SHH in the Cerebral Cortex Rise after Invasive
Injury
The experiments described above uncovered a profound differ-
ence in the incidence of astrocyte proliferation and in vitro neu-
rosphere formation elicited by invasive (stab wound, MCAo)
versus noninvasive injury, such as amyloidosis or p25-induced
neuronal death. To gain insight into the molecular basis for
this differential response, we focused on pathways previously
suggested to regulate the proliferation of reactive glia andCell Stem Cell 12, 426–439, April 4, 2013 ª2013 Elsevier Inc. 429
Figure 3. Neurosphere Formation by Cells Isolated from Different Injury Models
(A) Examples of neurospheres formed by cells of the SEZ, the cerebral cortex 3 days after stab wound (SW) or after induction of MCAo, or the cortex of APPPS1-
6mo mice after 14 days in culture. The data for all injury models tested are depicted in (B). (C) Representative micrographs show cells derived from primary
APPPS1-6mo neurospheres, differentiated for 7 days, and immunostained for the cell-type-specific markers indicated. Histograms in (B) and (D) depict the
numbers of primary (1, white bars) and secondary (2, gray bars) neurospheres (Nsph) per 10,000 cells isolated. The histogram in (E) shows the numbers of
neurospheres generated by cells from stab-wounded or APPPS1 animals at different ages. All data are means (±SEM) per independent experiment, and
significant differences are indicated based on the p value. Number of independent experiments analyzed for (B): SEZ, n = 6; GM of intact Ctx, n = 3; lesioned Ctx
after SW, n = 8, or MCAo, n = 11; APPPS1, n = 8; CK/p25, n = 3; for (D): n = 3 for each condition; for (E): n = 3, per group and time point after injury. For additional
analysis of neurosphere formation, see Figure S3. Scale bars: (A), 100 mm; (C), 20 mm.
Cell Stem Cell
SHH Mediates Stem Cell Response of Reactive Gliameasured levels of phosphorylated STAT3 (pSTAT3) and c-Jun
(pc-Jun) (Figure S4) and levels of SHH (Amankulor et al., 2009;
Gadea et al., 2008; Robel et al., 2011a; Sofroniew, 2009; Tsuda
et al., 2011). Only levels of SHH were found to correlate with the
proliferative and stem cell response. Both forms of SHH, the
monomer (25 kDa) and the multimer (52 kDa), were detected
in the GM of the cerebral cortex and their levels increased signif-
icantly on the ipsilateral side between 1 and 5 dpi (Figures 4A
and 4B). Intriguingly, a similar increase was observed 3 days
after MCAo (Figure 4B), while no noteworthy changes in
amounts of SHH were detected in the cerebral cortex of430 Cell Stem Cell 12, 426–439, April 4, 2013 ª2013 Elsevier Inc.APPPS1, CK/p25 (Figures 4C and 4D), or APP23 mice (Fig-
ure S3E). Taken together, these data demonstrate that SHH is
upregulated specifically in injurymodels that display a significant
increase in macroglia proliferation and neurosphere formation in
response to insult.
To determine the source of the increase in SHH after stab
wound injury, we used immunostaining and in situ hybridization.
In accordance with previous data (Alvarez et al., 2011; Amanku-
lor et al., 2009; Garcia et al., 2010; Traiffort et al., 1999), we
detected SHH mRNA and protein in neurons of the cerebral
cortex, both in the absence of injury and in the region around
Figure 4. SHH Expression in the Cerebral Cortex of Different Injury Models
(A–D) Western blot analysis with mAb 5E1 of SHH protein in tissue lysates of intact somatosensory cerebral cortex, or the cortical region ipsilateral (ipsi) or
contralateral (contra) to a stab wound, isolated at the indicated times (days post injury, dpi) after infliction of the injury (A) or from the mouse lines indicated in (C).
Recombinant mouse SHH protein was used as a positive control (+). The histograms in (B) and (D) depict the quantitative analysis of western blots by densi-
tometry normalized to the actin loading control and the contralateral (B) or intact cortex (D) (intact Ctx, n = 9; n = 3 per time point after SW; MCAo, n = 3; APPPS1,
n = 3; CK/p25, n = 3). All data are mean (±SEM) per independent experiment, and significant differences are indicated based on the p value. Micrographs in (E)
show immunostaining for SHH (5E1), GFAP, and NeuN. SHH+ cells are indicated by arrowheads and SHH cells by empty arrowheads. Micrographs in (F) show
SHH mRNA in control and stab-wounded (5 dpi) hemispheres hybridized with antisense (F and F0) and sense (F00) probes (for FISH see Bozoyan et al., 2012) and
(G) shows a western blot of CSF lysates prepared 5 dpi or from intact, noninjured mice. For additional analysis, see Figures S3 and S4. Scale bars: (E), 75 mm;
(E0 and E00), 30 mm; (F–F00), 50 mm.
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SHH Mediates Stem Cell Response of Reactive Gliathe stab wound (Figures 4E and 4F). Immunoreactivity and
mRNA was also detected in some astrocytes and endothelial
cells, especially after injury, but these cells made only a minor
contribution to the total signal (data not shown). Because extra-
neural fluids infiltrate the brain parenchyma after invasive injury,
we checked the cerebrospinal fluid (CSF), and found significantamounts of SHH (Figure 4G), suggesting that extraneural
sources contribute to the higher SHH levels seen in the brain
after invasive injury. It should be noted here that, while the
stab wound does not penetrate the ventricles, it does disrupt
the subarachnoid space overlying the cerebral cortex, which
contains CSF.Cell Stem Cell 12, 426–439, April 4, 2013 ª2013 Elsevier Inc. 431
Figure 5. Effects of Application of the SHH Agonist SAG In Vitro and In Vivo
Histograms in (A) and (B) depict the number of neurospheres generated from GM cells isolated 1, 3, 5, and 7 dpi (n = 3 per time point) and cultured under the
conditions indicated by the color of the bars. (C) Neurosphere-derived cells isolated from the intact cerebral cortex and cultured in SHH-, EGF-, and FGF2-
containing medium showed their multipotency by differentiating into bIII tubulin+ neurons, GFAP+ astrocytes, and O4+ oligodendrocytes. (D) Western blot
analysis of the SHH transducer Smoothened (Smo) in lysates of GFP+ andGFP cells from intact or stab-wounded cerebral cortex of hGFAP-eGFPmice purified
by FACS. Micrographs in (E–G) depict examples of immunostaining with the indicated antibodies of sections obtained from SAG- (F and G) or saline-treated
(legend continued on next page)
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SHH Mediates Stem Cell Response of Reactive GliaSHHSignaling IsNecessary andSufficient for the In Vitro
Stem Cell Response after Injury
In order to determine the functional significance of SHH for the
stem cell response of reactive glia, we first asked whether addi-
tion of SHH protein to the in vitro neurosphere assay affected the
capacity of isolated cells to generate neurospheres. Quantitative
assessment of cultures prepared from cortical GM at 1, 3, 5, and
7 dpi revealed a significant increase in neurosphere formation in
the presence of 5 nM SHH in cultures derived from 3 and 5 dpi
cells compared with control cultures (Figure 5A). This effect
could be blocked by the addition of cyclopamine (5 mM) (Fig-
ure 5A), a known inhibitor of SHH signaling (Chen et al., 2002).
Because cyclopamine also interfered with neurosphere forma-
tion in cultures to which no SHH was added, these data confirm
the release of endogenous SHH by neurosphere cells under
these culture conditions (Gabay et al., 2003). The specificity of
the effect of added SHH and its blockade by cyclopamine was
further corroborated by experiments with SAG, which activates
the SHH signal transducer Smoothened (Smo) (Frank-Kamenet-
sky et al., 2002). Thus, supplementation of cultures with SAG
significantly enhanced neurosphere formation by cells sur-
rounding the stab wound site (Figure 5B). Strikingly, both SHH
(data not shown) and SAG were sufficient to elicit neurosphere
formation from GM that had not been subjected to injury (Fig-
ure 5B). Thus, activation of the SHH pathway in vitro is sufficient
to enable formation of multipotent neurospheres (Figure 5C) by
cells isolated from GM of the cerebral cortex of adult mice,
even in the absence of prior insult.
SHH-Mediated Signaling Promotes Proliferation of
Reactive Astrocytes In Vivo
Since neurosphere-forming cells originate from reactive astro-
cytes, we purified hGFAP-eGFP+ reactive astrocytes by fluores-
cence-activated cell sorting (FACS) and found Smo to be highly
enriched in reactive astrocytes with expression level increased
at 1 dpi, while it was virtually undetectable in cell lysates derived
from GFP cells (Figure 5D). These findings indicate that reac-
tive astrocytes not only constitute the major source of neuro-
sphere-forming cells but are also capable of responding to the
increased levels of SHH observed in injured tissue. This promp-
ted us to investigate whether direct activation of Smo by SAG is
also sufficient to enhance the proliferative response of reactive
astrocytes in vivo. After daily treatment with SAG (0.15 mg/
10 g body weight) and addition of BrdU in the drinking water
for 5 days after stab wounding, the number of BrdU+ cells
around the injury site had increased significantly relative to
controls (Figures 5E, 5F, and 5H). Moreover, there was a signifi-
cant rise in proliferating reactive astrocytes, as measured by
BrdU incorporation over the 5 days (BrdU+/GFAP+) and re-
flected in the number of astrocytes still proliferating at 5 dpi
(labeled by Ki67) (Figures 5G and 5H). These data demonstrate
that in vivo levels of SHH are not saturating and that glial cell
proliferation, as well as neurosphere formation, can be further
boosted by treatment with agonists of Smo. This finding is of(E and G) animals. The insets (E0) and (F0) show higher magnifications and the
indicate the site of injury. Quantitative analysis of these experiments is depic
independent experiment, and significant differences are indicated based on the
100 mm; (G), 30 mm.particular relevance in light of the decrease in the endogenous
response with aging.
It seems likely that signalingmolecules other thanSHHare also
relevant for the proliferative and stem cell response of reactive
astrocytes. We therefore wished to assess the relative contribu-
tion of the SHH pathway to the overall process. To do so, we in-
jected cyclopamine or 2-hydroxypropyl-b-cyclodextrin (HBC)
(vehicle) intraperitoneally (i.p.) daily after stab wound injury and
isolated the cells surrounding the injury site for the neurosphere
assay as described above. Strikingly, virtually no neurospheres
could be generated from cells obtained from cyclopamine-
treatedmice, while vehicle injection did not perturb the formation
of neurospheres after stab wounding (Figure 6A). Real-time qRT-
PCR of astrocytes isolated from hGFAP-eGFP mice at 5 dpi re-
vealed that cyclopamine significantly decreased levels ofmRNAs
for Smo, Ptch1, SHH, Gli1–3, and their effector cyclin D1 (Fig-
ure 6B; see also Figure S5 for cell death analysis). These data
argue that the drastic reduction in proliferation of reactive astro-
cytes from cyclopamine-treated mice is largely attributable to
interference with SHH signaling.
However, cyclopamine may well affect cells other than reac-
tive astrocytes, and could thereby exert indirect effects via other
signaling pathways. To determine the effect of direct SHH
signaling to astrocytes, we examined whether removal of its
transducer from astrocytes affected their proliferative and stem
cell response after stab wounding. To this end, we conditionally
deleted the Smo gene (Long et al., 2001) in astrocytes
by GLASTCreERT2-mediated recombination, monitored by the
GFP reporter as described above. Animals heterozygous for
GLASTCreERT2, positive for the GFP reporter, and homozygous
(GLASTCreERT2;Smofl/fl;CAG-eGFP) or negative (GLASTCreERT2;
Smo+/+;CAG-eGFP) for the floxed Smo allele were exposed to
tamoxifen at 3 months of age and were subjected to stab injury
3months later. A large proportion of the reactive astrocytes iden-
tified by GFAP expression at 5 dpi had undergone recombina-
tion, as indicated by the presence of the GFP reporter. In control
(Smo+/+) animals, 53.4% ± 8.9% of GFAP+ cells are GFP+, while
the corresponding value for Smofl/flmice is 59.3% ± 7.2%. Strik-
ingly, selective deletion of Smo in GLASTCreERT2;Smofl/fl;CAG-
eGFP animals significantly reduces the degree of proliferation
(fraction of Ki67+ cells) of the recombined GFP+ cells to one-
third of that seen in the controls (GLASTCreERT2;Smo+/+;CAG-
eGFP) that received the same dose of tamoxifen at 3 months
(Figures 6F–6H). Hence, these data demonstrate a pronounced
direct effect of SHH signaling via the Smo transducer in astro-
cytes, with this pathway accounting for 60% of the increase in
their proliferative activity after stab wound injury. Because we
cannot distinguish between GFP+ cells that carry one or two re-
combinant floxed alleles, and because many cells may still have
remnant levels of Smo, the effects might well be even greater if
Smo could be eliminated from all astrocytes. Notably, the stem
cell response (monitored by neurosphere formation) obtained
from cells surrounding the stab wound in GLASTCreERT2;
Smofl/fl;CAG-eGFP mice was also reduced by about two-thirdswhite arrowheads indicate double- or triple-labeled cells. The dashed lines
ted in the histograms in (H). All data are represented as mean (±SEM) per
p value. For additional analysis see Figure S5. Scale bar: (C), 50 mm; (E and F),
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Figure 6. Effects of Inhibition/Deletion of Smoothened on Astrocyte Proliferation In Vivo and Stem Cell Properties In Vitro
(A) Numbers of neurospheres formed by cells isolated after stab wounding followed by three daily injections with either the diluent HBC (SW+HBC) or
cyclopamine (SW+Cyclo, n = 3 for each condition).
(B) Levels of the indicated mRNAs in GFP+ cells purified by FACS from cyclopamine-treated hGFAP-eGFP mice at 3 dpi, as determined by qRT-PCR, shown
relative to values for SW+HBC controls.
(C) Recombination efficiency, as monitored by the incidence of GFP+ cells, in the intact cerebral cortex of GLASTCreERT2;Smo+/+;CAG-eGFP and
GLASTCreERT2;Smofl/fl;CAG-eGFP mice exposed to tamoxifen at 3 months of age and analyzed 3 months later (n = 3).
(legend continued on next page)
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SHH Mediates Stem Cell Response of Reactive Gliacompared to control (Smo+/+) animals (Figures 6I and 6J).
Conversely, neurosphere formation from the SEZ of
GLASTCreERT2;Smofl/fl;CAG-eGFP mice was reduced by only
about 30%, suggesting that signals other than SHH may be of
more relevance in the SEZ than in the cortex after stab injury.
These data further corroborate the specificity and efficiency of
Smo deletion by GLASTCreERT2 and suggest a direct effect of
SHH signaling on the proliferative response of reactive astro-
cytes in vivo and on their stem cell potential in vitro.
DISCUSSION
Reactive gliosis occurs as a widespread reaction to brain
damage or injury. Here we have demonstrated profound differ-
ences in the nature of this reaction to invasive versus noninvasive
injury conditions. While aspects of morphological activation,
such as hypertrophy, and upregulation of characteristic proteins,
like GFAP, occurred in all the injury models examined here,
pronounced differences were observed in the proliferative
responses of distinct glial subsets depending on the type of
injury. In contrast to microglia, which proliferated at high
frequency in all pathology models and at all different ages exam-
ined here, reactive astrocytes proliferate very little in chronic
amyloidosis (1% of astrocytes; see also Kamphuis et al., 2012)
and not at all upon p25-induced neuronal cell death. This low
degree of proliferation was observed despite pronounced hyper-
trophy of GFAP+ astrocytes accompanied by upregulation of
proteins also expressed in NSCs (Gates et al., 1995), such as
nestin, DSD1, and TNC (Robel et al., 2011a) (Table 1). Thus,
upregulation of these proteins neither reflects the acquisition
of in vitro stem cell properties nor is associated with a robust
in vivo proliferative response. In contrast, both the proliferative
response and the capacity for neurosphere formation was mark-
edly increased following stab wound or ischemic injury (see
Table 1 and Buffo et al., 2008; Simon et al., 2011; Denes et al.,
2007). Most striking is the absence of any proliferative reaction
by astrocytes or NG2 glia in the presence of the extensive
neuronal death induced by p25 overexpression in neurons.
Thus, neuronal cell death does not trigger proliferation of macro-
glia, despite their intricate contacts with neurons at synapses.
This concept of a distinct reaction of macroglial cell proliferation
is further supported by recent data from the zebrafish model,
which reveal differences in proliferation of Olig2 glia under
different injury conditions, while division of microglia increases
under all lesion conditions (Baumgart et al., 2012; Kroehne
et al., 2011; Ma¨rz et al., 2011).
The Stem Cell Response of Astrocytes Is Injury
Dependent
The differential proliferative reaction of macroglial cells corre-
lates with the emergence of neurosphere-forming cells in the(D–H) Representative micrographs of cortical sections obtained from mice of th
Quantitative summaries of the data are shown in (E) and (H).
(I) Micrographs of neurospheres generated from cells isolated from the su
GLASTCreERT2;Smo+/+;CAG-eGFP and GLASTCreERT2;Smofl/fl;CAG-eGFP mice.
(J) Data from (I), quantified.
All data are plotted as mean (±SEM) per independent experiment (n = 3 per co
additional analysis see also Figure S5. Scale bars: (C) and (I), 150 mm; (D), 100 minjury models examined here. We consider this to be a stem
cell response because cells activate the capacity to self-renew
and generate all three CNS cell types in vitro. This shows that
they acquire NSC potential, even though not all of these features
can be realized in vivo. While the stem cell response of reactive
glia is highest under conditions of acute injury, such as stab
wounding and MCAo (Lang et al., 2004; Shimada et al., 2012),
it is significantly reduced in models of amyloidosis. This was
the case for cells isolated from the cerebral cortex of APPPS1
as well as APP23 mice, ruling out potential side effects of PS1
expression in neurons of APPPS1. Importantly, stab wound
injury in mice with intense amyloidosis could still elicit the stem
cell response to a similar extent as in control mice, clearly
demonstrating that a lack of inducing signals, rather than toxicity
or damage to the reactive glia, is responsible for the limited stem
cell response.
Strikingly, the stem cell response was entirely absent in the
case of the massive neuronal cell death elicited in the cerebral
cortex by induced p25 overexpression. Not a single self-renew-
ing neurosphere was generated from cortical cells isolated from
such mice, nor could any reactivation of astrocyte proliferation
be observed 2 or 5 weeks after p25 overexpression induced by
doxycycline withdrawal. Because this covers the time of onset
of neuronal death and reactive gliosis, it is unlikely that the
stem cell reaction occurred at an earlier stage. Moreover, BrdU
was supplied in the drinking water for the entire period after
doxycycline withdrawal, but we still failed to detect any prolifer-
ation of astrocytes, the neurosphere-forming cells. Thus, the
death of many neurons in the cerebral cortex is not sufficient
to elicit a stem cell response from reactive astrocytes.
SHH Is Necessary and Sufficient to Elicit a Stem Cell
Response from Reactive Astrocytes
Because these results suggested that a lack of inducing signals
is responsible for the failure of reactive astrocytes to display
proliferative and stem cell responses in noninvasive injury
models, both the low levels of SHH observed in the cortex after
profound amyloidosis or p25-induced cell death and the signifi-
cantly elevated levels of SHH seen after stab wound injury and
stroke, together with SHH’s presence in endogenous stem cell
niches (Lai et al., 2003; Machold et al., 2003), provided a hint
that SHH might play a positive role in the stem cell reaction.
Notably, neurons, astrocytes, and choroid plexus cells have
been described as sources of SHH (Alvarez et al., 2011; Aman-
kulor et al., 2009; Garcia et al., 2010; Traiffort et al., 1999), and
the presence of considerable amounts of SHH in CSF (Huang
et al., 2009) may help to explain why invasive injuries result in
the accumulation of significant levels of the signal (Amankulor
et al., 2009; Androutsellis-Theotokis et al., 2006), while the
noninvasive models, such as amyloidosis or p25 induced neu-
ronal death, do not. Interestingly, SHH is also present in humane indicated genotypes and analyzed for the indicated antigens (D, F, and G).
bependymal zone (SEZ) or the GM of stab-wounded cerebral cortex of
ndition), and significant differences are indicated based on the p value. For
m; (F) and (G), 120 mm.
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Table 1. Summary of Reactive Gliosis in Distinct Models of AD Pathology and Invasive Injury
Cell-Type-Specific Reaction
(in Cortical GM) Intact CNS
Alzheimer Pathology
Stab Wound Injury, 5 dpiAPP CK/p25
Cell morphology astrocytes radiating fine processes hypertrophy of cell
soma/processes
hypertrophy of cell
soma/processes
hypertrophy of cell
soma/processes
NG2+ glia highly branched, fine
processes
thicker processes,
enlarged soma
highly branched, fine
processes
thicker processes,
enlarged soma
microglia highly branched, fine
processes
few processes,
hypertrophy
few processes,
hypertrophy
few processes,
hypertrophy
Proliferative
capacity
astrocytes nonproliferative (<0.5%) low contribution to
proliferative pool
(2.7% ± 0.2%)
low contribution to
proliferative pool
(0.9% ± 0.3%)
high contribution
(22.5% ± 1.6%)
NG2+ glia proliferative (99%) high contribution
(41.1% ± 9%)
high contribution
(48.9% ± 7.7%)
high contribution
(24.8% ± 3.6%)
microglia nonproliferative (<0.5%) highest contribution
(56.2% ± 7.4%)
highest contribution
(50.1% ± 2.9%)
highest contribution
(46.2% ± 1.6%)
Stem cell
response
neurosphere-
forming capacity
no (<0.001%) yes (0.007% ± 0.002%) virtually none
(0.003% ± 0.003%)
yes (0.081% ± 0.004%)
multipotency
(glial: neuronal)
no (glial) yes (2:1) yes (2:1) yes (2:1)
self-renewal no yes (0.126% ± 0.027%) no yes (0.366% ± 0.059%)
activity of SHH
pathway
basal level not significantly
upregulated
not significantly
upregulated
significantly
upregulated
Proliferative capacity refers to the relative contribution of each of the different glial cell types (mean ± SEM) to the total population of BrdU+ cells deter-
mined per 1 mm2 of the cortical GM in brain sections after double-immunostaining with BrdU and cell-type-specific markers (NG2 for NG2-expressing
oligodendroglia, GFAP/S100b for astroglia, and Iba1 formicroglia). The neurosphere-forming capacity is expressed as the percentage (mean ±SEM) of
neurosphere-generating cells per 10,000 cells obtained from the somatosensory cortex of the adult mouse brain. The self-renewal capacity refers to
the fraction of the neurosphere-forming cells per 10,000 cells obtained from dissociated primary neurosphere cultures.
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to the brain after invasive injury in patients.
Importantly, we were able to demonstrate that SHH signaling
is both necessary and sufficient to promote the proliferative
response in vivo and neurosphere formation in vitro by acting
directly on reactive astrocytes. Astrocytes express the SHH
transducer Smoothened, and its selective deletion in these cells
impairs their proliferation in vivo and their potential to form neu-
rospheres in vitro. Notably, early postnatal deletion of Smooth-
ened in astrocytes also induced a partially reactive phenotype
with GFAP upregulation but no evidence for astrocyte prolifera-
tion (Garcia et al., 2010). Taken together, these results imply
a U-shaped model for the action of SHH, with both too low
and too high levels of SHH signaling activating reactive gliosis
and higher levels triggering an additional proliferative response.
Alternatively, SHH signaling may specifically interact with other
pathways, e.g., Notch or BMP signaling (Androutsellis-Theotokis
et al., 2006; Sehgal et al., 2009) at early postnatal stages to drive
astrocyte maturation to completion.
Interestingly, addition of SHH or the Smo agonist SAG in vitro
and in vivo not only boosted the proliferative response of reactive
astrocytes as well as their neurosphere-forming capacity, but
was even sufficient to elicit neurosphere formation from cells of
the cerebral cortex GM in the absence of any injury. This is
particularly important with regard to the aging-related decline
in the proliferative and stem cell response upon injury. Interest-
ingly, intrathecal application of SHH resulted in significant
improvement of neurological outcome in a rat model of stroke436 Cell Stem Cell 12, 426–439, April 4, 2013 ª2013 Elsevier Inc.(Bambakidis et al., 2012). These beneficial effects relate to the
pleiotropic effects of SHH, which promotes blood-brain barrier
integrity and anti-inflammatory effects (Alvarez et al., 2011),
has a neuroprotective action (Hashimoto et al., 2008), and
boosts proliferation in endogenous neurogenic niches and in
the cerebral cortex after injury (Sims et al., 2009; Machold
et al., 2003; Lai et al., 2003). Finally, SHH activity has been impli-
cated in regeneration in many models (for review see Antos and
Tanaka, 2010; Stoick-Cooper et al., 2007), suggesting that it has
a widespread positive effect on wound healing and repair. Thus,
the pleiotropic actions of SHH are likely to exert several benefi-
cial effects after brain injury, in addition to promoting the stem
cell response of reactive gliosis.
Indeed, it is important to bear in mind that the discovery of
a particularly plastic and immature set of reactive astrocytes is
of great significance, not only because these cells may be
more easily persuaded to adopt desirable fates (for review see
Robel et al., 2011a; Shimada et al., 2012), but also because
more immature glia, such as radial glial cells, may have many
other beneficial aspects, such as promoting neurite outgrowth
and synapse formation, while scar-forming reactive astrocytes
often inhibit it, thereby restricting rewiring after brain injury (Fitch
and Silver, 2008). Taken together, our work highlights key differ-
ences in the proliferative and stem cell response of reactive glia
in different injury paradigms and has identified a key signaling
pathway, which provides a novel perspective for efforts to
stimulate this endogenous stem cell response for therapeutic
purposes.
Cell Stem Cell
SHH Mediates Stem Cell Response of Reactive GliaEXPERIMENTAL PROCEDURES
Animals
APPPS1 mice (Radde et al., 2006) were maintained on a C57Bl/6 background
(Charles River Laboratories; Sulzfeld, Germany) and C57Bl/6 mice were used
as controls. For genetic tracing of astrocytes, APPPS1 mice were crossed with
GLASTCreERT2mice (Mori etal., 2006) and theCAG-eGFP reporter line (Nakamura
etal., 2006).Recombinationwas inducedbyadministrationof tamoxifenasprevi-
ously described (Mori et al., 2006). For selective deletion of Smo in astrocytes,
homozygous mice carrying floxed Smo alleles (Smofl/fl, Long et al., 2001),
GLASTCreERT2 mice (Mori et al., 2006), and the CAG-eGFP reporter line (Naka-
mura et al., 2006) were used. Genotypeswere determined by PCR using primers
listed in the Supplemental Information. CK/p25 animals (Cruz et al., 2003) were
raised on doxycycline (0.05 g/l doxycycline/1.5% sucrose in drinking water) until
6 weeks of age. Littermates that did not harbor any transgene were used as
controls and exposed to doxycycline in the same way as experimental animals.
Surgical Procedures
Unilateral stab wound (0.7 mm deep and 1 mm long) was performed in the
somatosensory cortex of C57Bl/6 mice as previously described (Buffo et al.,
2008; Simon et al., 2011). For focal ischemia, adult C57Bl/6 male mice were
subjected to transient MCAo for 60 min according to the intraluminal filament
model (Plesnila et al., 2004). I.p.) injections of cyclopamine (10 mg/kg, Sigma
Aldrich) diluted in HBC, (Sigma Aldrich) were performed every 24 hr while
control animals received injections ofHBConly. SAG (Calbiochem)was admin-
istered orally (0.15 mg in 0.5% methylcellulose/0.2% Tween80 per 10 g body
weight) once a day for 5 days. CSFwas sampled from the cisternamagna using
a glass capillary and was microscopically inspected for blood contamination.
All experimental procedures were performed in accordance with the animal
welfare policies of, and approved by, the State of Bavaria.
Immunohistochemistry
After transcardial perfusion, brains were cryoprotected, and sections (30 mm)
were processed for immunohistochemistry as previously described (Simon
et al., 2011) with the antibodies listed in the Supplemental Information.
Proliferating cells were labeled with BrdU (Sigma Aldrich) added to the
drinking water (1 mg/ml water containing 1% sucrose) for 5 or 14 consecutive
days. BrdU incorporation was monitored in free-floating sections pretreated
with 0.01 M sodium citrate (pH 6) at 95C for 20 min.
Neurosphere Culture
Neurosphere cultures were prepared as previously described (Buffo et al.,
2008) using a volume of tissue punched (B 0.35 cm) from the lesioned and non-
lesioned areas of the (stabbed or MCAo-injured) somatosensory cerebral
cortex or the corresponding anatomical areas of APPPS1 and CK/p25 mice.
After removal of meninges and white matter, GM cells were plated at a density
of one to five cells/ml in 600 ml of neurosphere medium with FGF2 and EGF
(both at 20 ng/ml, Invitrogen). In parallel sets, SHH (5 nM, R&D), cyclopamine
(5 mM, Sigma Aldrich), or SAG (0.5 mM, Calbiochem) was added at the begin-
ning of the experiment only. The number of neurospheres was quantified after
14 div and individual neurospheres were assessed for self-renewal or differen-
tiation as described in Buffo et al. (2008).
Western Blot
The same tissue volume (B 0.35 cm) or 1 ml of CSF was used for western blot
analysis with the antibody 5E1 (Developmental Studies Hybridoma Bank,
University of Iowa, IA) as described by Ohlig et al. (2011). Anti-Smo (Santa
Cruz Biotechnology), anti-actin, and immunoreactive bands were revealed
by chemiluminescent detection (Pierce) of peroxidase-conjugated, subtype-
specific antibody (mouse IgG, Dianova) or LICOR.
Quantification and Statistical Analysis
Confocal laser scanning (Zeiss LSM5; Zeiss LSM710) or epifluorescence
(Zeiss, Axiophot; Olympus BX61) microscopes were used to quantify immuno-
positive cells in sections or cell culture. For each quantification at least three
animals or experimental culture batches were examined. All quantifications
of immunostainings are based on analysis of at least five sections per animal,
and the incidence of immunopositive cells is expressed either relative to thetotal cell number (5,000–7,000 DAPI-stained nuclei per section) or the number
of GFP+ cells in the case of reporter mice. Data were tested for normal distri-
bution and significance tests were chosen accordingly (two-tailed unpaired
Student’s t test or two-tailed Mann-Whitney test). Data were plotted as
mean per section/culture ± SEM and significance was indicated as *p <
0.05, **p < 0.01, and ***p < 0.001. Quantitative analysis of western blots was
performed by densitometry of both SHH bands (52 kDa multimers and
25 kDamonomers), and the valueswere pooled and expressed relative to actin
normalized to the contralateral or intact cortex.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes five figures and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2013.01.019.
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